Advancements in Rheumatoid Arthritis Treatment and Immunology

This chapter explores groundbreaking research in rheumatoid arthritis, focusing on how autoantibody profiles influence disease progression and treatment efficacy. It highlights the promising results of the treatment BataCet and the critical need for refined risk signatures to tailor expensive therapies. Additionally, the chapter addresses the complexities of immune responses to checkpoint inhibitors, emphasizing advancements in technologies like single-cell RNA sequencing, which enhance understanding of autoimmune diseases.